Oncimmune Holdings plc reported earnings results for the fifteen months ended August 31, 2022. For the fifteen months, the company reported sales was GBP 3.79 million. Net loss was GBP 11.39 million.

Basic loss per share from continuing operations was GBP 0.1649. Diluted loss per share from continuing operations was GBP 0.1649.